A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier BV in Antiviral Research
- Vol. 195, 105183
- https://doi.org/10.1016/j.antiviral.2021.105183
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Targeting Human Papillomavirus Genome Replication for Antiviral Drug DiscoveryAntiviral Therapy, 2013
- Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and CoronavirusesJournal of Virology, 2012
- A Fluorogenic Red Fluorescent Protein HeterodimerCell Chemical Biology, 2012
- Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up StudyThe Journal of Immunology, 2011
- Profiling of Substrate Specificity of SARS-CoV 3CLproPLOS ONE, 2010
- Recombination, Reservoirs, and the Modular Spike: Mechanisms of Coronavirus Cross-Species TransmissionJournal of Virology, 2010
- Duration of Antibody Responses after Severe Acute Respiratory SyndromeEmerging Infectious Diseases, 2007
- Disappearance of Antibodies to SARS-Associated Coronavirus after RecoveryThe New England Journal of Medicine, 2007
- Production of Authentic SARS-CoV Mpro with Enhanced Activity: Application as a Novel Tag-cleavage Endopeptidase for Protein OverproductionJournal of Molecular Biology, 2007
- WebLogo: A Sequence Logo Generator: Figure 1Genome Research, 2004